Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-11-13

Clinical Trial Update: Aspirin on CTCs of Advanced Breast and Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating aspirin's effect on circulating tumor cells in advanced breast cancer and advanced colorectal cancer; the status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Zhejiang Provincial People's Hospital | Conditions: Epithelial-Mesenchymal Transition, Circulating Tumor Cells | Phase 2 | Status: UNKNOWN